FINWIRES · TerminalLIVE
FINWIRES

蒙特福特資本宣布其董事會成員辭職

By

-- 蒙特福特資本(Montfort Capital,股票代號:MONT.V)週一宣布,珍妮絲·萊德曼(Janice Lederman)和保羅·蓋爾(Paul Geyer)已於4月26日辭去董事會職務。該公司目前暫無任命繼任者的計劃,理由是現有董事會成員組成與其業務規模相符。 另據報道,科特蘭信貸貸款公司(Cortland Credit Lending Corporation)向Pivot Financial I L.P.發出了部分信貸協議項下的還款要求,蒙特福特和朗豪斯金融公司(Langhaus Financial Corporation)為其提供了擔保。蒙特福特表示,其證券交易已於4月24日暫停。 經過週末的磋商,雙方已撤回還款要求,並尋求替代方案。該公司表示,將適時向股東通報最新進展。 蒙特福特股票最後一次交易是在上週五,在多倫多證券交易所創業板(TSX Venture Exchange)收在0.015加幣。

Related Articles

Asia

Ora Banda Mining Appoints Chair-elect

Ora Banda Mining (ASX:OBM) has appointed John Richards as chair-elect, with plans for him to assume the role following the retirement of current Chair Peter Mansell at the company's annual general meeting in November, according to a Tuesday filing with the Australian bourse.Richards is currently non-executive chair of Sandfire Resources (ASX:SFR) and lead independent non-executive director of Sheffield Resources (ASX:SFX), the filing added.

$ASX:OBM$ASX:SFR$ASX:SFX
Research

Research Alert: Universal Health Services: Q1 Eps Tops Estimates

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:UHS delivered solid Q1 results, with adjusted EPS of $5.62 (up 16.1% Y/Y), $0.16 above consensus, while revenue grew 9.6% to $4.495B due to higher prices despite modest patient volumes. Same-facility acute care revenue increased 8.2% on flat adjusted admissions but 6.3% growth in revenue per admission, while behavioral health saw 1.2% admission growth and 7.3% revenue growth. We think the $835M Talkspace acquisition may expand UHS's virtual behavioral health capabilities and broaden payor mix. Management expects the deal to close in Q3. Operating cash flow improved 11.7% to $402M, and UHS repurchased $127.3M in stock, though adjusted EBITDA margin compressed 20 bps to 14.4% on higher operating expenses. We think behavioral health staffing challenges persist but expect the Talkspace integration to create growth opportunities.

$UHS
Research

Research Alert: Cls Q1: Blistering Fy 26 Guidance And Cpo Win Tempered By Capital Demands

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Q1 revenues of $4.05B (+53%) and adjusted EPS of $2.16 (+80%) both exceeded guidance on accelerating hyperscaler demand. Adjusted operating margin reached a record 8.0%, due to higher-value CCS offerings, which grew 76% to $3.24B, with segment margin expanding to 8.6%. The company secured a new CPO switch program with a hyperscaler customer expected to ramp in 2027, and we expect more color tomorrow. Management raised 2026 guidance to $19.0B revenue (from $17.0B) and $10.15 adjusted EPS (from $8.75), representing over $6.5B in revenue growth. Stronger growth is anticipated for 2027 based on improved customer visibility and new program wins. The company enlarged its balance sheet by upsizing its credit facility to $2.5B, with revolver capacity increased to $1.75B. FCF of $137.9M remained robust despite elevated capex of $218.4M to support capacity expansion. Share buybacks slowing, FCF guidance lagging, and a +50% month may be contributing to the after-hours selloff.

$CLS